Big Gain For Jounce Therapeutics, Inc.
Wed, Mar 15, 2023 at 07:06 PM
Jounce Therapeutics, Inc. (JNCE:NASDAQ) jumped higher at $1.49, representing a gain of 40.6%. On Wed, Mar 15, 2023, JNCE:NASDAQ hit a New 2-Week High of $1.49. The stock appeared on our News Catalysts scanner on Sat, Mar 11, 2023 at 10:06 AM in the 'MISCELLANEOUS' category. From Wed, Mar 01, 2023, the stock recorded 40.00% Up Days and 54.55% Green Days
About Jounce Therapeutics, Inc. (JNCE:NASDAQ)
Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.
Top 10 Gainers:
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 98.58%
- Elevation Oncology Inc. (ELEV:NASDAQ), 62.24%
- Loyalty Ventures Inc. (LYLT:NASDAQ), 59.35%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 40.57%
- Mmtec, Inc. (MTC:NASDAQ), 35.75%
- Creatd Inc. (CRTD:NASDAQ), 32.74%
- Moolec Science SA (MLEC:NASDAQ), 25.16%
- Summit Healthcare Acquisition Corp. (SMIH:NASDAQ), 22.3%
- Etao International Co. Ltd. (ETAO:NASDAQ), 21.52%
- GreenLight Biosciences Holdings PBC (GRNA:NASDAQ), 21.46%